Overview
Perrigo Poland operates in the healthcare products sector, offering over-the-counter medicines and other self-care products. The company distributes products in Poland and supports consumers and healthcare professionals with information about their use.
Financials
The financial statement for 2024 has not yet been filed with the Financial Document Repository (past deadline).
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2023.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2003-12-31. Active
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
No public aid cases recorded in the last 10 years.
Tenders
No recorded participation in tenders.
Trademarks
Perrigo Poland holds 1 active trademark registered with the Polish Patent Office. The first mark was filed in 2010.
| Mark | Protected until | |
|---|---|---|
| ROMBALSAM(word) | Oct 8, 2030 |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
The company is represented by each member of the management board independently, or by an independently acting commercial proxy, or by two joint commercial proxies.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Perrigo Pharma Holding Nederland B.v. | 57,713 | $7,794,840.63 | 74.2643% |
Perrigo Holding Nv | 20,000 | $2,701,242.57 | 25.7357% |
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Natur Produkt Zdrovitsp. z o.o. | $205,379,396.79 | zdrovit.pl | ||
| Bialmedsp. z o.o. | $203,238,055.12 | bialmed.pl | ||
| Roche Diagnostics Polskasp. z o.o. | $199,208,461.57 | roche.pl | ||
| Servier Polska Servicessp. z o.o. | $157,143,144.15 | servier.pl | ||
| Gilead Sciences Polandsp. z o.o. | $150,844,944.19 | gilead.com | ||
| LubfarmS.A. | $123,208,945.21 | lubfarm.pl | ||
| Vershold Polandsp. z o.o. | $108,410,848.82 | vershold.com | ||
| Magnapharm Polandsp. z o.o. | $90,512,785.67 | magnapharm.pl | ||
| Chiesi Polandsp. z o.o. | $87,762,158.97 | chiesi.pl | ||
| Croda Polandsp. z o.o. | $35,516,661.48 | croda.com |
Change history
| Date | Event | |
|---|---|---|
| 2024-08-22 | Address change (Al. Niepodległości 18, 02-653, Warszawa → Ul. Domaniewska 48, 02-672, Warszawa) | |
| 2020-02-20 | Name change (Omega Pharma Poland → Perrigo Poland) | |
| 2012-09-06 | Address change (Dąbrowskiego 247/249, 93-232, Łódź → Al. Niepodległości 18, 02-653, Warszawa) | |
| 2012-08-08 | Share capital change (24,691,500.00 PLN → 38,856,500.00 PLN) | |
| 2010-12-22 | Share capital change (13,329,000.00 PLN → 24,691,500.00 PLN) |
FAQ
Last updated: 2026-09-18